newsfilter
← Latest News
GlobeNewswire·

PLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business Update

- Significant Reduction in Operating Expenses - Strategic Alternatives Process Ongoing Total Net Sales of $0.4 Million, Including $0.3 Million of Unfavorable Adjustments for Additional Trade Allowances and